サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1625409

個別化医療バイオマーカー市場、規模、シェア、動向、産業分析レポート：適応症別、用途別、地域別 - 市場予測、2025年～2034年

Personalized Medicine Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Indication, Application, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 128 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
個別化医療バイオマーカー市場、規模、シェア、動向、産業分析レポート：適応症別、用途別、地域別 - 市場予測、2025年～2034年
出版日: 2024年12月01日
発行: Polaris Market Research
ページ情報: 英文 128 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、個別化医療バイオマーカーの市場規模は2034年までに782億7,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

個別化医療バイオマーカー市場は、標的治療と精密医療に対する需要の高まりにより急速に成長しています。バイオマーカーは、疾患リスクの予測、病態の診断、治療反応のモニタリングに使用される生物学的指標です。バイオマーカーの応用は、腫瘍学、神経学、循環器学、自己免疫疾患などの重要な分野にわたっており、個別化アプローチによって患者の転帰が大幅に向上します。

市場成長は、正確な診断・治療ソリューションの開発を可能にするゲノムおよびプロテオミクス革新を含むバイオマーカー技術の進歩によって推進されます。がん、糖尿病、心血管疾患などの慢性疾患の有病率の増加は、バイオマーカーの需要をさらに増大させ、早期発見、治療選択、モニタリングなどの市場成長に寄与しています。

製薬会社、診断会社、研究機関の戦略的パートナーシップはバイオマーカー開発と採用を加速しており、個別化医療バイオマーカー市場に大きなビジネスチャンスをもたらしています。さらに、高齢化社会では慢性疾患や加齢に関連した疾患に罹患しやすくなるため、この層の治療を個別化するためのバイオマーカーに対する需要が高まっています。

個別化医療バイオマーカー市場レポートハイライト

用途別では、患者個人のプロファイルに合わせた精密治療に対する需要の高まりから、2024年には治療選択分野が市場の最大シェアを占めました。

適応症に基づく糖尿病セグメントは、糖尿病の世界の有病率の上昇により、予測期間で最も高いCAGRが見込まれています。

2024年には、研究開発への多額の投資により北米が個別化医療バイオマーカー市場を独占しました。

アジア太平洋市場は、慢性疾患の有病率の上昇により、予測期間中に大幅な成長が見込まれています。

世界の主要市場企業には、Laboratory Corporation of America Holding、Quest Diagnostics Incorporated、Agilent Technologies, Inc.、Genome Medical, Inc.、Coriell Life Sciences、Thermo Fisher Scientific Inc.、NeoGenomics Laboratories、FOUNDATION MEDICINE, INC.、Illumina, Inc.、Guardant Healthなどがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の個別化医療バイオマーカー市場の洞察

  • 市場スナップショット
  • 個別化医療バイオマーカー市場力学
    • 促進要因と機会
      • 慢性疾患の蔓延
      • 製薬会社と診断会社の連携の拡大
    • 抑制要因と課題
      • 高い開発コスト
  • PESTEL分析
  • 個別化医療バイオマーカー市場のアプリケーション動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の個別化医療バイオマーカー市場：適応症別

  • 主な調査結果
  • イントロダクション
  • 腫瘍学
  • 神経学
  • 糖尿病
  • 自己免疫疾患
  • 心臓病学
  • その他

第6章 世界の個別化医療バイオマーカー市場：用途別

  • 主な調査結果
  • イントロダクション
  • 早期発見・スクリーニング
  • 診断
  • 治療の選択
  • 監視

第7章 世界の個別化医療バイオマーカー市場：地域別

  • 主な調査結果
  • イントロダクション
    • 個別化医療バイオマーカー市場評価：地域別、2020年～2034年
  • 北米
    • 北米：適応症別、2020年～2034年
    • 北米：用途別、2020年～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：適応症別、2020～2034年
    • 欧州：用途別、2020年～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：適応症別、2020年～2034年
    • アジア太平洋：用途別、2020年～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：適応症別、2020～2034年
    • 中東・アフリカ：用途別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：適応症別、2020年～2034年
    • ラテンアメリカ：用途別、2020年～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携 / 協業 / 合意 / 公開

第9章 企業プロファイル

  • Laboratory Corporation of America Holding
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc.
  • Genome Medical, Inc.
  • Coriell Life Sciences.
  • Thermo Fisher Scientific Inc.
  • NeoGenomics Laboratories
  • FOUNDATION MEDICINE, INC.
  • Illumina, Inc.
  • Guardant Health
図表

List of Tables:

Table 1 Global Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 2 Global Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 3 North America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 4 North America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 5 US: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 6 US: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 7 Canada: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 8 Canada: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 9 Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 10 Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 11 UK: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 12 UK: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 13 France: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 14 France: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 15 Germany: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 16 Germany: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 17 Italy: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 18 Italy: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 19 Spain: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 20 Spain: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 21 Netherlands: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 22 Netherlands: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 23 Russia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 24 Russia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 25 Rest of Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 26 Rest of Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 27 Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 28 Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 29 China: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 30 China: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 31 India: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 32 India: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 33 Malaysia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 34 Malaysia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 35 Japan: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 36 Japan: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 37 Indonesia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 38 Indonesia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 39 South Korea: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 40 South Korea: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 41 Australia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 42 Australia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 43 Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 44 Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 45 Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 46 Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 47 Saudi Arabia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 48 Saudi Arabia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 49 UAE: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 50 UAE: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 51 Israel: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 52 Israel: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 53 South Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 54 South Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 55 Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 56 Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 57 Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 58 Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 59 Mexico: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 60 Mexico: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 61 Brazil: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 62 Brazil: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 63 Argentina: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 64 Argentina: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 65 Rest of Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 66 Rest of Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Personalized Medicine Biomarkers Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Indication

Figure 7. Global Personalized Medicine Biomarkers Market, by Indication, 2024 & 2034 (USD Billion)

Figure 8. Market by Application

Figure 9. Global Personalized Medicine Biomarkers Market, by Application, 2024 & 2034 (USD Billion)

目次
Product Code: PM5290

The personalized medicine biomarkers market size is expected to reach USD 78.27 billion by 2034, according to a new study by Polaris Market Research. The report "Personalized Medicine Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Indication, Application (Early Detection/Screening, Diagnosis, Treatment Selection, and Monitoring), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The personalized medicine biomarkers market is rapidly growing due to the rising demand for targeted therapies and precision medicine. Biomarkers are biological indicators used to predict disease risk, diagnose conditions, and monitor treatment response. Biomarker applications are across critical areas such as oncology, neurology, cardiology, and autoimmune diseases, where personalized approaches significantly enhance patient outcomes.

Market growth is propelled by advancements in biomarker technologies, including genomic and proteomic innovations, which enable the development of precise diagnostic and therapeutic solutions. The increasing prevalence of chronic conditions such as cancer, diabetes, and cardiovascular diseases further amplifies the demand for biomarkers, contributing to market growth such as early detection, treatment selection, and monitoring.

Strategic partnerships between pharmaceutical companies, diagnostic firms, and research organizations are accelerating biomarker development and adoption, creating significant personalized medicine biomarkers market opportunities. Furthermore, the aging population is more prone to chronic and age-related conditions, creating a higher demand for biomarkers to personalize treatments for this demographic.

Personalized Medicine Biomarkers Market Report Highlights

In terms of application, in 2024, the treatment selection segment accounted for the largest share of the market due to the growing demand for precision therapies tailored to individual patient profiles.

The diabetes segment, based on indication, is expected to witness the highest CAGR over the forecast period due to the rising global prevalence of diabetes.

In 2024, North America dominated the personalized medicine biomarkers market due to due to significant investments in research and development.

The Asia Pacific market is expected to witness significant growth over the forecast period due to the rising prevalence of chronic diseases.

A few global key market players include Laboratory Corporation of America Holding; Quest Diagnostics Incorporated; Agilent Technologies, Inc.; Genome Medical, Inc.; Coriell Life Sciences; Thermo Fisher Scientific Inc.; NeoGenomics Laboratories; FOUNDATION MEDICINE, INC.; Illumina, Inc.; Guardant Health.

Polaris Market Research has segmented the personalized medicine biomarkers market report on the indication, application, and region:

By Indication Outlook (Revenue, USD Billion; 2020-2034)

  • Oncology
  • By Type
  • § Breast Cancer
  • § Lung Cancer
  • § Colon Cancer
  • § Others
  • By Circulating Biomarkers
  • § Circulating Tumor Cells(CTCs)
  • § Circulating Cell-free DNA(cfDNA)
  • § Extracellular Vesicles (EVs)
  • § Other Circulating Biomarkers
  • Neurology
  • Diabetes
  • Autoimmune Diseases
  • Cardiology
  • Others

By Application Outlook (Revenue, USD Billion; 2020-2034)

  • Early Detection/Screening
  • Diagnosis
  • Treatment Selection
  • Monitoring

By Regional Outlook (Revenue, USD Billion; 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Personalized Medicine Biomarkers Market Insights

  • 4.1. Personalized Medicine Biomarkers Market - Market Snapshot
  • 4.2. Personalized Medicine Biomarkers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic Diseases
      • 4.2.1.2. Rising Collaboration Between Pharmaceutical and Diagnostics Companies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Development Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Personalized Medicine Biomarkers Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Personalized Medicine Biomarkers Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
  • 5.3. Oncology
    • 5.3.1. Global Personalized Medicine Biomarkers Market, by Oncology, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Type
      • 5.3.2.1. Global Personalized Medicine Biomarkers Market, by Type, by Region, 2020-2034 (USD Billion)
      • 5.3.2.2. Breast Cancer
      • 5.3.2.2.1. Global Personalized Medicine Biomarkers Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
      • 5.3.2.3. Lung Cancer
      • 5.3.2.3.1. Global Personalized Medicine Biomarkers Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
      • 5.3.2.4. Colon Cancer
      • 5.3.2.4.1. Global Personalized Medicine Biomarkers Market, by Colon Cancer, by Region, 2020-2034 (USD Billion)
      • 5.3.2.5. Others
      • 5.3.2.5.1. Global Personalized Medicine Biomarkers Market, by Others, by Region, 2020-2034 (USD Billion)
    • 5.3.3. Circulating Biomarkers
      • 5.3.3.1. Global Personalized Medicine Biomarkers Market, by Circulating Biomarkers, by Region, 2020-2034 (USD Billion)
      • 5.3.3.2. Circulating Tumor Cells(CTCs)
      • 5.3.3.2.1. Global Personalized Medicine Biomarkers Market, by Circulating Tumor Cells(CTCs), by Region, 2020-2034 (USD Billion)
      • 5.3.3.3. Circulating Cell-free DNA(cfDNA)
      • 5.3.3.3.1. Global Personalized Medicine Biomarkers Market, by Circulating Cell-free DNA(cfDNA), by Region, 2020-2034 (USD Billion)
      • 5.3.3.4. Extracellular Vesicles (EVs)
      • 5.3.3.4.1. Global Personalized Medicine Biomarkers Market, by Extracellular Vesicles (EVs), by Region, 2020-2034 (USD Billion)
      • 5.3.3.5. Other Circulating Biomarkers
      • 5.3.3.5.1. Global Personalized Medicine Biomarkers Market, by Other Circulating Biomarkers, by Region, 2020-2034 (USD Billion)
  • 5.4. Neurology
    • 5.4.1. Global Personalized Medicine Biomarkers Market, by Neurology, by Region, 2020-2034 (USD Billion)
  • 5.5. Diabetes
    • 5.5.1. Global Personalized Medicine Biomarkers Market, by Diabetes, by Region, 2020-2034 (USD Billion)
  • 5.6. Autoimmune Diseases
    • 5.6.1. Global Personalized Medicine Biomarkers Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
  • 5.7. Cardiology
    • 5.7.1. Global Personalized Medicine Biomarkers Market, by Cardiology, by Region, 2020-2034 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Personalized Medicine Biomarkers Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Personalized Medicine Biomarkers Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Early Detection/Screening
    • 6.3.1. Global Personalized Medicine Biomarkers Market, by Early Detection/Screening, by Region, 2020-2034 (USD Billion)
  • 6.4. Diagnosis
    • 6.4.1. Global Personalized Medicine Biomarkers Market, by Diagnosis, by Region, 2020-2034 (USD Billion)
  • 6.5. Treatment Selection
    • 6.5.1. Global Personalized Medicine Biomarkers Market, by Treatment Selection, by Region, 2020-2034 (USD Billion)
  • 6.6. Monitoring
    • 6.6.1. Global Personalized Medicine Biomarkers Market, by Monitoring, by Region, 2020-2034 (USD Billion)

7. Global Personalized Medicine Biomarkers Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Personalized Medicine Biomarkers Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Personalized Medicine Biomarkers Market - North America
    • 7.3.1. North America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.2. North America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.3.3. Personalized Medicine Biomarkers Market - US
      • 7.3.3.1. US: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.3.3.2. US: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.3.4. Personalized Medicine Biomarkers Market - Canada
      • 7.3.4.1. Canada: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.4. Personalized Medicine Biomarkers Market - Europe
    • 7.4.1. Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.3. Personalized Medicine Biomarkers Market - UK
      • 7.4.3.1. UK: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.4. Personalized Medicine Biomarkers Market - France
      • 7.4.4.1. France: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.5. Personalized Medicine Biomarkers Market - Germany
      • 7.4.5.1. Germany: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.6. Personalized Medicine Biomarkers Market - Italy
      • 7.4.6.1. Italy: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.7. Personalized Medicine Biomarkers Market - Spain
      • 7.4.7.1. Spain: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.8. Personalized Medicine Biomarkers Market - Netherlands
      • 7.4.8.1. Netherlands: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.9. Personalized Medicine Biomarkers Market - Russia
      • 7.4.9.1. Russia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.10. Personalized Medicine Biomarkers Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.5. Personalized Medicine Biomarkers Market - Asia Pacific
    • 7.5.1. Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.3. Personalized Medicine Biomarkers Market - China
      • 7.5.3.1. China: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.4. Personalized Medicine Biomarkers Market - India
      • 7.5.4.1. India: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.5. Personalized Medicine Biomarkers Market - Malaysia
      • 7.5.5.1. Malaysia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.6. Personalized Medicine Biomarkers Market - Japan
      • 7.5.6.1. Japan: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.7. Personalized Medicine Biomarkers Market - Indonesia
      • 7.5.7.1. Indonesia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.8. Personalized Medicine Biomarkers Market - South Korea
      • 7.5.8.1. South Korea: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.9. Personalized Medicine Biomarkers Market - Australia
      • 7.5.9.1. Australia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.10. Personalized Medicine Biomarkers Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.6. Personalized Medicine Biomarkers Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.3. Personalized Medicine Biomarkers Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.4. Personalized Medicine Biomarkers Market - UAE
      • 7.6.4.1. UAE: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.5. Personalized Medicine Biomarkers Market - Israel
      • 7.6.5.1. Israel: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.6. Personalized Medicine Biomarkers Market - South Africa
      • 7.6.6.1. South Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.7. Personalized Medicine Biomarkers Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.7. Personalized Medicine Biomarkers Market - Latin America
    • 7.7.1. Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.7.3. Personalized Medicine Biomarkers Market - Mexico
      • 7.7.3.1. Mexico: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.7.4. Personalized Medicine Biomarkers Market - Brazil
      • 7.7.4.1. Brazil: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.7.5. Personalized Medicine Biomarkers Market - Argentina
      • 7.7.5.1. Argentina: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.7.6. Personalized Medicine Biomarkers Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Laboratory Corporation of America Holding
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Quest Diagnostics Incorporated
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Agilent Technologies, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Genome Medical, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Coriell Life Sciences.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Thermo Fisher Scientific Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. NeoGenomics Laboratories
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. FOUNDATION MEDICINE, INC.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Illumina, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Guardant Health
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development